Fenaux P - Search Results

1

Adès L, Itzykson R, Fenaux P. Adès L, et al. Among authors: fenaux p. Lancet. 2014 Jun 28;383(9936):2239-52. doi: 10.1016/S0140-6736(13)61901-7. Epub 2014 Mar 21. Lancet. 2014. PMID: 24656536 Review.

2

Chromosome and molecular abnormalities in myelodysplastic syndromes.

Fenaux P. Fenaux P. Int J Hematol. 2001 Jun;73(4):429-437. doi: 10.1007/BF02994004. Int J Hematol. 2001. PMID: 11503956 Review.

3

Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.

Leroy H, Roumier C, Grardel-Duflos N, Macintyre E, Lepelley P, Fenaux P, Preudhomme C. Leroy H, et al. Among authors: fenaux p. Blood. 2002 May 15;99(10):3848-50. doi: 10.1182/blood.v99.10.3848. Blood. 2002. PMID: 11986246 Free article.

4

[ Myelodysplastic syndrome].

Fenaux P. Fenaux P. Rev Prat. 2002 Dec 15;52(20):2301-8. Rev Prat. 2002. PMID: 12621953 Review. French. No abstract available.

5

A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.

Prébet T, Ducastelle S, Debotton S, Stamatoullas A, Deconinck E, Fruchart C, Gratecos N, Ifrah N, Dreyfus F, Fenaux P, Wattel E; Groupe Français des Myélodysplasies (GFM), France. Prébet T, et al. Among authors: fenaux p. Hematol J. 2004;5(3):209-15. doi: 10.1038/sj.thj.6200363. Hematol J. 2004. PMID: 15167906 Clinical Trial.

6

Myelodysplastic syndromes: From pathogenesis and prognosis to treatment.

Fenaux P. Fenaux P. Semin Hematol. 2004 Apr;41(2 Suppl 4):6-12. doi: 10.1053/j.seminhematol.2004.02.002. Semin Hematol. 2004. PMID: 15190510 Review.

7

DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinat B, Parry A, Walz C, Wiemels JL, Segal MR, Adès L, Blair IA, Osheroff N, Peniket AJ, Lafage-Pochitaloff M, Cross NC, Chomienne C, Solomon E, Fenaux P, Grimwade D. Mistry AR, et al. Among authors: fenaux p. N Engl J Med. 2005 Apr 14;352(15):1529-38. doi: 10.1056/NEJMoa042715. N Engl J Med. 2005. PMID: 15829534 Free article.

8

Supportive care including growth factors in myelodysplastic syndromes.

Gardin C, Fenaux P. Gardin C, et al. Among authors: fenaux p. Rev Clin Exp Hematol. 2004 Dec 1;8(2):E3. Rev Clin Exp Hematol. 2004. PMID: 16027101 Review.

9

Response assessments in low-risk and high-risk myelodysplastic syndromes (MDS).

Fenaux P. Fenaux P. Semin Oncol. 2005 Aug;32(4 Suppl 5):S11-5. doi: 10.1053/j.seminoncol.2005.06.016. Semin Oncol. 2005. PMID: 16085012 Review.

10

Inhibitors of DNA methylation: beyond myelodysplastic syndromes.

Fenaux P. Fenaux P. Nat Clin Pract Oncol. 2005 Dec;2 Suppl 1:S36-44. doi: 10.1038/ncponc0351. Nat Clin Pract Oncol. 2005. PMID: 16341239 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

903 results

Search Page